Cargando…

2767. Impact of iron limitation on in vitro and in vivo activity of ceftazidime against A. baumannii

BACKGROUND: Acinetobacter baumannii (AB) is known to have high rates of multidrug resistance (MDR), new treatment options are critically needed to prevent further spread and mortality. Deferiprone (DFP), a metal chelator, has been shown to induce transient growth inhibition in previous studies, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eales, Brianna, Smith, James, Hudson, Cole, Pouya, Nazanin, Tam, Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678399/ http://dx.doi.org/10.1093/ofid/ofad500.2378

Ejemplares similares

500. Impact of an iron chelator on in vitro and in vivo growth of A. baumannii
por: Eales, Brianna, et al.
Publicado: (2022)

1313. MIC Profiling of Ceftazidime-Avibactam (CAZ/AVI) Against Two Carbapenemase producing Klebsiella pneumoniae Isolates
por: Zidaru, Andrei, et al.
Publicado: (2020)

Induction of apoptosis by the ADEPT agent ZD2767: comparison with the classical nitrogen mustard chlorambucil and a monofunctional ZD2767 analogue
por: Monks, N R, et al.
Publicado: (2001)

Vérification de la conformité de colis de transport de radionucléides Type A modèles 2767R et 2767T
por: Greffion, Chloe
Publicado: (2016)

Experimental Validation of a Mathematical Framework to Simulate Antibiotics with Distinct Half-Lives Concurrently in an In Vitro Model
por: Eales, Brianna M., et al.
Publicado: (2021)

Genome Sequence of the Autotrophic Acetogen Clostridium magnum DSM 2767
por: Uhlig, Ronny, et al.
Publicado: (2016)

2542. Attenuation of Polymyxin and Aminoglycoside-Associated Nephrotoxicity
por: Hudson, Cole, et al.
Publicado: (2023)

Development of ZD2767P–carboxypeptidase G2–ultrasound therapy against cisplatin-resistant cancer
por: Yu, Tinghe, et al.
Publicado: (2023)

In vitro activities of colistin, imipenem and ceftazidime against drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolates in the south of Iran
por: Malekzadegan, Yalda, et al.
Publicado: (2019)

Evolution of Acinetobacter baumannii In Vivo: International Clone II, More Resistance to Ceftazidime, Mutation in ptk
por: Hua, Xiaoting, et al.
Publicado: (2017)

2767. Variation in Incidence of Pediatric Herpes Zoster by First- and Second-Dose Varicella Vaccine Formulations
por: Weinmann, Sheila, et al.
Publicado: (2019)

Clinical and genomic analysis of virulence-related genes in bloodstream infections caused by Acinetobacter baumannii
por: Bai, Bing, et al.
Publicado: (2022)

In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase–producing Klebsiella pneumoniae
por: Zhang, Wenxia, et al.
Publicado: (2018)

Acetylcysteine increases sensitivity of ceftazidime-avibactam–resistant enterobacterales with different enzymatic resistance to ceftazidime-avibactam in vitro and in vivo
por: Huang, Zeyu, et al.
Publicado: (2023)

Comparison of the in vitro and in vivo susceptibilities of Burkholderia mallei to Ceftazidime and Levofloxacin
por: Judy, Barbara M, et al.
Publicado: (2009)

In vivo translational assessment of the GES genotype on the killing profile of ceftazidime, ceftazidime/avibactam and meropenem against Pseudomonas aeruginosa
por: Gill, Christian M, et al.
Publicado: (2022)

Biological Control of Acinetobacter baumannii: In Vitro and In Vivo Activity, Limitations, and Combination Therapies
por: Havenga, Benjamin, et al.
Publicado: (2022)

In vitro and in vivo Antimicrobial Activities of Ceftazidime/Avibactam Alone or in Combination with Aztreonam Against Carbapenem-Resistant Enterobacterales
por: Lu, Guoping, et al.
Publicado: (2022)

In Vitro and In Vivo Activity of AS101 against Carbapenem-Resistant Acinetobacter baumannii
por: Yang, Tsung-Ying, et al.
Publicado: (2021)

Investigation of the human pathogen Acinetobacter baumannii under iron limiting conditions
por: Eijkelkamp, Bart A, et al.
Publicado: (2011)

In vitro and in vivo synergistic effect of chrysin in combination with colistin against Acinetobacter baumannii
por: Zhao, Yining, et al.
Publicado: (2022)

Ultrasonically Enhanced ZD2767P–Carboxypeptidase G2 Deactivates Cisplatin-Resistant Human Lung Cancer Cells
por: Liu, Qianfen, et al.
Publicado: (2022)

In vivo efficacy & resistance prevention of cefiderocol in combination with ceftazidime/avibactam, ampicillin/sulbactam or meropenem using human-simulated regimens versus Acinetobacter baumannii
por: Gill, Christian M, et al.
Publicado: (2023)

In vitro activities of cellulase and ceftazidime, alone and in combination against Pseudomonas aeruginosa biofilms
por: Kamali, Esmat, et al.
Publicado: (2021)

In vitro activity of cefiderocol against comparators (ceftazidime-avibactam, ceftazidime-avibactam/ aztreonam combination, and colistin) against clinical isolates of meropenem-resistant Klebsiella pneumoniae from India
por: Borde, Kalyani, et al.
Publicado: (2023)

2109. In vitro and in vivo Killing Kinetics of Zosurabalpin (RG6006) Against Acinetobacter baumannii
por: Erbetti, Isabelle, et al.
Publicado: (2023)

Avibactam potentiated the activity of both ceftazidime and aztreonam against S. maltophilia clinical isolates in vitro
por: Lin, Qiuxia, et al.
Publicado: (2021)

Cellular glutathione as a determinant of the sensitivity of colorectal tumour cell-lines to ZD2767 antibody-directed enzyme prodrug therapy (ADEPT)
por: Monks, N R, et al.
Publicado: (2000)

In vitro, in vivo and clinical studies comparing the efficacy of ceftazidime-avibactam monotherapy with ceftazidime-avibactam-containing combination regimens against carbapenem-resistant Enterobacterales and multidrug-resistant Pseudomonas aeruginosa isolates or infections: a scoping review
por: Aslan, Abdullah Tarık, et al.
Publicado: (2023)

Bacterial membrane vesicles from Acinetobacter baumannii induced by ceftazidime are more virulent than those induced by imipenem
por: Chiu, Chun-Hsiang, et al.
Publicado: (2020)

Preparation, characterization and in vitro antimicrobial activity of liposomal ceftazidime and cefepime against Pseudomonas aeruginosa strains
por: Torres, Ieda Maria Sapateiro, et al.
Publicado: (2012)

Comparison of In Vitro Activity of Ceftazidime-Avibactam and Imipenem-Relebactam against Clinical Isolates of Pseudomonas aeruginosa
por: Wang, Leilei, et al.
Publicado: (2023)

Ceftazidime-avibactam
por: Matesanz, Mayra, et al.
Publicado: (2021)

Ceftazidime-avibactam
por: Herrero, Francisco Sanz
Publicado: (2022)

In vitro and in vivo analysis of antimicrobial agents alone and in combination against multi-drug resistant Acinetobacter baumannii
por: He, Songzhe, et al.
Publicado: (2015)

In vitro and in vivo Activity of Combinations of Polymyxin B with Other Antimicrobials Against Carbapenem-Resistant Acinetobacter baumannii
por: Zhang, Hui, et al.
Publicado: (2021)

In Vitro and In Vivo Antimicrobial Activity of the Novel Peptide OMN6 against Multidrug-Resistant Acinetobacter baumannii
por: Michaeli, Janna, et al.
Publicado: (2022)

In vitro and in vivo evaluation of two combined β-lactamase inhibitors against carbapenem-resistant Acinetobacter baumannii
por: Domínguez, Andrea Vila, et al.
Publicado: (2023)

Iron and Acinetobacter baumannii Biofilm Formation
por: Gentile, Valentina, et al.
Publicado: (2014)

Genomics of Acinetobacter baumannii iron uptake
por: Artuso, Irene, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lkmthg40c9gbekoj17mrhvtvuh